PAUL F TRUEX
CIK 1120362 · Executive Chaiman · last filed 2022-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.2K
Companies
4
Total Filings
58
Lifetime Open-Market Net
-$987.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MIST | Director | 8,016 | $1.27 | $10.2K | $28.0K | 4 | 2022-06-01 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 8 | 2021-01-28 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Executive Chaiman | 21,801 | — | — | -$1.03M | 39 | 2018-01-09 |
| Trius Therapeutics Inc (TSRX) Delisted | Director | 13,270 | — | — | $17.1K | 6 | 2013-05-23 |
Recent Filings · Page 6 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-01-04 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-11-24 | Trius Therapeutics Inc (TSRX) Delisted | Mixed | +8,364 | $13.0K | EDGAR |
| 2010-11-05 | Trius Therapeutics Inc (TSRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-07-14 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Gift (G) | −23,364 | $0 | EDGAR |
| 2010-07-02 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | +86,000 | $0 | EDGAR |
| 2010-04-07 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Exer (M) | +23,364 | $3.3K | EDGAR |
| 2010-03-05 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Conv (C) | +29,286 | $0 | EDGAR |
| 2010-03-02 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Buy (P) | +1,000 | $7.1K | EDGAR |
Showing 51–58 of 58
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.